| BTS guidelines for the management of community acquired pneumonia in adults: update 2009 WS Lim, SV Baudouin, RC George, AT Hill, C Jamieson, I Le Jeune, ... Thorax 64 (Suppl 3), iii1-iii55, 2009 | 1995 | 2009 |
| Guidelines for the management of adult lower respiratory tract infections‐Full version M Woodhead, F Blasi, S Ewig, J Garau, G Huchon, M Ieven, A Ortqvist, ... Clinical microbiology and infection 17, E1-E59, 2011 | 1618 | 2011 |
| International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital … A Torres, MS Niederman, J Chastre, S Ewig, P Fernandez-Vandellos, ... European Respiratory Journal 50 (3), 2017 | 1023 | 2017 |
| ESCMID guideline: diagnosis and treatment of acute bacterial meningitis D Van de Beek, C Cabellos, O Dzupova, S Esposito, M Klein, AT Kloek, ... Clinical microbiology and infection 22, S37-S62, 2016 | 935 | 2016 |
| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 728 | 2021 |
| Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised … X Liu, RH Shaw, ASV Stuart, M Greenland, PK Aley, NJ Andrews, ... The Lancet 398 (10303), 856-869, 2021 | 519 | 2021 |
| Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults B Killingley, AJ Mann, M Kalinova, A Boyers, N Goonawardane, J Zhou, ... Nature Medicine 28 (5), 1031-1041, 2022 | 494 | 2022 |
| Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium CPJ Amitani R, Wilson R, Rutman A, Read R, Ward C, Burnett D, Stockley RA American Journal of Respiratory Molecular and Cell Biology 4 (1), 26-32, 1991 | 406* | 1991 |
| Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis CJ Nile, RC Read, M Akil, GW Duff, AG Wilson Arthritis & Rheumatism 58 (9), 2686-2693, 2008 | 402 | 2008 |
| Liver abscess in adults: ten years experience in a UK centre AH Mohsen, ST Green, RC Read, MW McKendrick Qjm 95 (12), 797-802, 2002 | 369 | 2002 |
| Macrophage defences against respiratory tract infections: The immunology of childhood respiratory infections SB Gordon, RC Read British medical bulletin 61 (1), 45-61, 2002 | 354 | 2002 |
| Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower … M Woodhead, F Blasi, S Ewig, J Garau, G Huchon, M Ieven, A Ortqvist, ... Clin Microbiol Infect 17 (Suppl 6), E1-E59, 2011 | 345 | 2011 |
| Toll-like receptors in health and disease: complex questions remain I Sabroe, RC Read, MKB Whyte, DH Dockrell, SN Vogel, SK Dower The journal of immunology 171 (4), 1630-1635, 2003 | 338 | 2003 |
| Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009) JS Nguyen-Van-Tam, PJM Openshaw, A Hashim, EM Gadd, WS Lim, ... Thorax 65 (7), 645-651, 2010 | 337 | 2010 |
| Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial RC Read, D Baxter, DR Chadwick, SN Faust, A Finn, SB Gordon, ... The Lancet 384 (9960), 2123-2131, 2014 | 316 | 2014 |
| von Willebrand factor is an acute phase reactant in man BE Pottinger, RC Read, EM Paleolog, PG Higgins, JD Pearson Thrombosis research 53 (4), 387-394, 1989 | 293 | 1989 |
| The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults F McGill, RS Heyderman, BD Michael, S Defres, NJ Beeching, R Borrow, ... Journal of Infection 72 (4), 405-438, 2016 | 275 | 2016 |
| Identification of In Vivo–Expressed Antigens of Staphylococcus aureus and Their Use in Vaccinations for Protection against Nasal Carriage SR Clarke, KJ Brummell, MJ Horsburgh, PW McDowell, SAS Mohamad, ... The Journal of infectious diseases 193 (8), 1098-1108, 2006 | 256 | 2006 |
| Effective nasal influenza vaccine delivery using chitosan RC Read, SC Naylor, CW Potter, J Bond, I Jabbal-Gill, A Fisher, L Illum, ... Vaccine 23 (35), 4367-4374, 2005 | 254 | 2005 |
| Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a … ASV Stuart, RH Shaw, X Liu, M Greenland, PK Aley, NJ Andrews, ... The Lancet 399 (10319), 36-49, 2022 | 241 | 2022 |
